Clinical Trial Update: 3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating three tipranavir/ritonavir dose regimens in antiretroviral-experienced people with HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• tipranavir/ritonavir (tipranavir/ritonavir)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 2 | Status: COMPLETED